RT Journal Article
SR Electronic
T1 SARS-CoV-2 Acquisition and Immune Pathogenesis Among School-Aged Learners in Four Diverse Schools
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.03.20.21254035
DO 10.1101/2021.03.20.21254035
A1 Dan M. Cooper
A1 Michael Z. Zulu
A1 Allen Jankeel
A1 Izabela Coimbra Ibraim
A1 Jessica Ardo
A1 Kirsten Kasper
A1 Diana Stephens
A1 Andria Meyer
A1 Annamarie Stehli
A1 Curt Condon
A1 Mary E. Londoño
A1 Casey M. Schreiber
A1 Nanette V. Lopez
A1 Ricky L. Camplain
A1 Michael Weiss
A1 Charles Golden
A1 Shlomit Aizik
A1 Bernadette Boden-Albala
A1 Clayton Chau
A1 Ilhem Messaoudi
A1 Erlinda R. Ulloa
YR 2021
UL http://medrxiv.org/content/early/2021/06/16/2021.03.20.21254035.abstract
AB Background Understanding SARS-CoV-2 infection in children is necessary to reopen schools safely.Methods We measured SARS-CoV-2 infection in 320 learners [10.5 ± 2.1(sd); 7-17 y.o.] at four diverse schools with either remote or on-site learning. Schools A and B served low-income Hispanic learners; school C served many special-needs learners; and all provided predominantly remote instruction. School D served middle- and upper-income learners, with predominantly on-site instruction. Testing occurred in the fall (2020), and 6-8 weeks later during the fall-winter surge (notable for a tenfold increase in COVID-19 cases). Immune responses and mitigation fidelity were also measured.Results We found SARS-CoV-2 infections in 17 learners only during the surge. School A (97% remote learners) had the highest infection (10/70, 14.3%, p<0.01) and IgG positivity rates (13/66, 19.7%). School D (93% on-site learners) had the lowest infection and IgG positivity rates (1/63, 1.6%). Mitigation compliance [physical distancing (mean 87.4%) and face covering (91.3%)] was remarkably high at all schools. Documented SARS-CoV-2-infected learners had neutralizing antibodies (94.7%), robust IFN-γ+ T cell responses, and reduced monocytes.Conclusion Schools can implement successful mitigation strategies across a wide range of student diversity. Despite asymptomatic to mild SARS-CoV-2 infection, children generate robust humoral and cellular immune responses.Key PointsSuccessful COVID-19 mitigation was implemented across a diverse range of schools.School-associated SARS-CoV-2 infections reflect regional rates rather than remote or on-site learning.Seropositive school-aged children with asymptomatic to mild SARS-CoV-2 infections generate robust humoral and cellular immunity.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNIH NCATS UCI Clinical and Translational Science Award UL1 TR001414; R01AI142841; R21AI143301; Orange County Health Care Agency Research Fund; UCI COVID-19 Research Fund; Support was provided in part by the Robert Wood Johnson Foundation and the National Institute of Allergy and Infectious Diseases, NIH (K08 AI151253-01) to ERU.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the institutional review boards at the Childrens Hospital of Orange County and the University of California IrvineAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data that support the findings of this study are openly available in medRxiv.CHOCChildren’s Hospital of Orange CountyOCHCAOrange County Health Care AgencySOCOMSystematic Observation of COVID-19 MitigationHDLhigh-density lipoproteinLDLlow-density lipoproteinPBMCsperipheral blood mononuclear cellsNPnucleocapsid proteinRBDreceptor binding domainNKnatural killer cellsmDCsmyeloid dendritic cellsPD-1programmed death cell protein 1MFImean fluorescence intensity